Stock PRLD PROLIGHT DIAGNOSTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

News Prolight Diagnostics AB

Equities

PRLD

SE0003618230

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
0.145 SEK +23.93% Intraday chart for Prolight Diagnostics AB +23.93% -51.83%
05-17 Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development MT
05-17 Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Prolight has obtained subscription commitments for exercising warrants of series TO6 from, among others, members of the Board and management of approximately SEK 1.0 million
AQ
BioStock: Prolight Diagnostics strengthens board with experienced business developer
AQ
Last day of trading with warrants of series TO6 in Prolight Diagnostics is today, May 28, 2024
AQ
Annual general meeting of Prolight Diagnostics AB (publ) on 27 May 2024
AQ
BioStock: Prolight Diagnostics CSO comments on latest data
AQ
Prolight on track for clinical performance studies
AQ
BioStock: Prolight Diagnostics' CTO thrilled to receive UK government grant
AQ
Equity Research | Prolight Diagnostics: SEK 17m UK grant a welcome external validation
AQ
Prolight initiates trial at London hospital Trust supported by an NIHR i4i PDA grant
AQ
The exercise period for warrants of series TO6 in Prolight Diagnostics begins today
AQ
Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development
MT
Prolight Diagnostics publishes quarterly report Q1, 2024
AQ
Prolight Diagnostics awarded SEK17M UK government grant in collaboration with leading UK hospital Trust
AQ
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
The exercise price for the warrants of series TO6 in Prolight Diagnostics has been determined to SEK 0.10 per share
AQ
BioStock: Prolight Diagnostics selects partner to conduct clinical validation studies
AQ
Prolight selects MDx CRO for the clinical performance studies for Psyros™
AQ
Prolight Diagnostics AB (publ) publishes annual report for 2023
AQ
BioStock: Prolight Diagnostics finalises cartridge design
AQ
NOTICE OF THE ANNUAL GENERAL MEETING IN PROLIGHT DIAGNOSTICS AB (PUBL)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRLD Stock
  4. News Prolight Diagnostics AB